<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02034539</url>
  </required_header>
  <id_info>
    <org_study_id>VADOplex-1</org_study_id>
    <nct_id>NCT02034539</nct_id>
  </id_info>
  <brief_title>VADOplex Critical Limb Ischemia Study</brief_title>
  <official_title>Prospektive, Randomisierte Und Kontrollierte Studie Zum Einfluss Des VADOplex-Systems Auf Die Lebensqualität im Rahmen Der Behandlung Der Chronisch-kritischen Extremitätenischämie im Stadium IV Nach Fontaine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asklepios Kliniken Hamburg GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OPED GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asklepios Kliniken Hamburg GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with critical limb ischemia (CLI) and foot ulcers wound healing is an important
      goal which can normally only be achieved after sufficient treatment of the underlying
      ischemia (revascularization either by an operation, e. g. bypass, or a catheter
      intervention). After successful revascularization everything should be done to improve wound
      healing because this regularly takes weeks up to several months. One possibility to speed up
      healing could be treatment with the VADOplex device which delivers an automatic intermittent
      painless compression of the sole of the foot thereby increasing perfusion of the leg. This
      system can be easily operated by patients themselves and at home.

      Our goal is to prove that the VADOPlex system accelerates healing up and improves quality of
      life.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>wound healing</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>complete healing of the target lesion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of quality of life</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>change of quality of life compared to baseline. Quality of life measured with the EQ-5D tool (European quality of life in 5 dimensions)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to complete wound healing</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>time until complete wound healing of the target lesion is achieved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound size</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>overall reduction of the size of the target lesion in patients with incomplete wound healing compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of pain intensity</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>change of pain intensity compared to baseline. Pain intensity measured with a numeric rating scale (0 - 10) or if not applicable with a visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of ankle-brachial index</measure>
    <time_frame>at discharge, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 24 weeks after discharge</time_frame>
    <description>change of ankle-brachial index compared to basleline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of deep vein thrombosis</measure>
    <time_frame>24 weeks after discharge or whenever a thrombosis is suspected</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <condition>Quality of Life</condition>
  <condition>Wound Healing</condition>
  <arm_group>
    <arm_group_label>VADOplex treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>best medical treatment in combination with intermittent pneumatic foot compression by the VADOplex system for 4 - 6 hours/day until total wound closure of the target lesion is achieved with a maximum treatment of 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conservative treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>best medical treatment of the target lesion alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VADOplex system</intervention_name>
    <description>intermittent automatic pneumatic compression of the sole of the foot by the VADOplex system</description>
    <arm_group_label>VADOplex treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed informend consent

          -  peripheral artery disease Fontaine IV (equals Ruterford 5 and 6) with or without
             neuropathy

          -  foot lesion stage 1 - 4 analogous to 4 Wagner classification of the diabetic foot

          -  secondary wound healing if previous surgical wound treatment

          -  previous interventional and/or surgical revascularisation

          -  age above 18

          -  hosptalized to the beginning of the study

        Exclusion Criteria:

          -  primary wound healing if previous surgical wound treatment

          -  uncontrolled local or systemic infection

          -  renal failure on dialysis

          -  inability or insufficient help to operate the VADOplex system

          -  wound dressings that lead to insufficient compression by the VADOplex system (e.g.
             total contact cast for offloading)

          -  wounds of other than ischemic or neuro-ischemic origin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Lawall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>head of department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claas Lüdemann, MD</last_name>
    <phone>+49 (0) 40 8191-2019</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Gefäßzentrum, Asklepios Westklinikum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22559</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claas Luedemann, MD</last_name>
      <phone>+49 (0) 40 8191-2019</phone>
    </contact>
    <investigator>
      <last_name>Claas Luedemann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2014</study_first_submitted>
  <study_first_submitted_qc>January 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2014</study_first_posted>
  <last_update_submitted>January 10, 2014</last_update_submitted>
  <last_update_submitted_qc>January 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asklepios Kliniken Hamburg GmbH</investigator_affiliation>
    <investigator_full_name>Claas Luedemann</investigator_full_name>
    <investigator_title>Claas Luedemann, MD</investigator_title>
  </responsible_party>
  <keyword>peripheral artery disease</keyword>
  <keyword>critical limb ischemia</keyword>
  <keyword>VADOplex</keyword>
  <keyword>intermittent foot compression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

